PSPriyanka Setia

Priyanka Setia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Priyanka Setia has a total of 96 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical, Genetic, and Immunological Spectrum of CHAI and LATAIE Patients from a Tertiary Referral Centre in India

    by Priyanka Setia, Umair Ahmed Bargir, Mukesh Desai, Aparna Dalvi, Shweta Shinde, Neha Jodhawat, Pallavi Gaikwad, Sagar Bhattad, Chandrakala Shainmukhaih, Maya Gupta, et al.

    Primary immune regulatory disorders (PIRDs) are a group of conditions characterised by a loss of immune tolerance. Two such disorders, CHAI and LATAIE, share common molecular mechanisms, leading to significant clinical overlap. Here, we report demographic, clinical, immunological, and molecular findings in 29 patients referred from different parts of India with a diagnosis of CHAI or LATAIE. LATAIE patients demonstrated a higher prevalence of consanguinity, while CHAI patients more often had a positive family history. Both disorders presented with overlapping clinical features, predominately autoimmune cytopenias, benign lymphoproliferation, and inflammatory bowel disease (IBD). However, the incidence of recurrent infections, otitis media, bronchiectasis, and hypogammaglobulinemia was higher among LATAIE patients as compared to CHAI. Flow cytometry analysis revealed significant differences in T cell subsets, particularly in percentages of CD4+ naïve cells and T regulatory cells (Treg), between the two disorders. B cell abnormalities were also observed. Molecular diagnosis was achieved using targeted or clinical exome sequencing, and specific protein expression was employed to validate the novel variants.

  • Open Access

    Mendelian susceptibility to mycobacterial disease: Clinical, immunological, and genetic study in India

    by Aparna Dalvi, Lavina Temkar, Mukesh Desai, Swati Garg, Jahnavi Aluri, Gouri Hule, Umair Ahmed Bargir, Priyanka Setia, Priyanka Kambli, Amruta Dhawale, et al.

    Mendelian susceptibility to mycobacterial disease (MSMD) is a rare syndrome characterized by increased and selective susceptibility to weakly virulent mycobacteria and other intramacrophagic pathogens. This study emphasizes the utility of immunological and functional assays in diagnosing MSMD by analyzing clinical, immunological, and genetic features in 50 Indian patients. Immunological workup included lymphocyte subset analysis, nitroblue tetrazolium test (NBT), and flow cytometric assessment of IFN-γR1 (CD119), IL-12Rβ1 (CD212), and phosphorylated STAT1/STAT4 following cytokine stimulation. Functional assays measured IFN-γ and IL-12p70 production. Genetic evaluation was performed using whole-exome or Sanger sequencing. The median age at onset was 3 mo. BCG complications were the most common presentation (96%), while 4% had non-tuberculous mycobacterial infections. Additional infections included Mycobacterium tuberculosis, Salmonella spp., Candida spp., and multiple types of viruses. IL-12Rβ1 deficiency was the most frequent diagnosis, with 10 novel variants in the IL12RB1 gene identified. These results demonstrate that combining flow cytometry with functional and genetic analyses enables accurate and timely MSMD diagnosis.

  • Open Access

    Common Variable Immunodeficiency Disorder: A Decade of Insights from a Cohort of 150 Patients in India and the Use of Machine Learning Algorithms to Predict Severity

    by Umair Ahmed Bargir, Priyanka Setia, Mukesh Desai, Chandrakala S, Aparna Dalvi, Shweta Shinde, Maya Gupta, Neha Jodhawat, Amrutha Jose, Mayuri Goriwale, et al.

    Common Variable Immunodeficiency (CVID) is a heterogeneous disorder characterized by impaired antibody production and recurrent infections. In this study we investigated the clinical and immunological features of CVID in Indian patients and develops a machine learning model for predicting disease severity. We retrospectively analyzed 150 patients diagnosed with CVID over a decade at a tertiary care center in India. The median age of diagnosis was 18 years, with a male predominance (62%). The majority of patients (66.6%) had a severe phenotype, with recurrent respiratory tract infections being the most common clinical manifestation (84.2%). Gastrointestinal complications were observed in 45% of patients, while autoimmune manifestations were seen in 21%. All patients exhibited hypogammaglobulinemia. IgA levels varied, with 7.8% normal and 14.5% undetectable. IgM levels were decreased in 85.5% of patients. B-cell analysis revealed 64.4% had reduced class-switched memory B cells, with 21.7% showing very low levels. Nine adult patients presented with late-onset combined immunodeficiency. Genetic testing, performed on 52 patients, identified underlying monogenic causes in 29 pediatric and 15 adult patients. LRBA deficiency was the most common genetic defect, found in seven pediatric and three adult patients. We developed a novel machine learning-based severity prediction model for CVID patients, utilizing readily available lymphocyte subsets, class-switched memory B cell counts, and serum immunoglobulin levels to provide an accessible and robust tool for predicting disease severity using Ameratunga’s clinical severity score. Random Forest outperformed other models across all metrics, achieving an accuracy of 0.853 (95% CI: 0.840–0.866). Feature importance analysis across all models identified Th-Tc ratio, CD19, and IgM levels as the most influential predictors for severity prediction. Our study highlights the diverse clinical and immunological features of CVID in Indian patients, emphasizing the need for early diagnosis and individualized management strategies. The machine learning model developed using commonly available immune parameters provide a robust tool for predicting disease severity, potentially guiding treatment strategies to improve patient outcomes.


  • Expanding the clinical phenotype of FADD deficiency with a novel mutation and its role in Fas‐mediated apoptotic pathway

    by Priyanka Setia, Umair Ahmed Bargir, Chandrakala Shanmukhaiah, Neha Jodhawat, Pallavi Gaikwad, Disha Vedpathak, Shubhankar Dutta, Rucha Kulkarni, Priyanka Kambli, Aparna Dalvi, et al.


  • Open Access

    Quality of life and low self-esteem: an alarming phase among elderly

    by Kavita Verma, Priyanka Setia, Priyanka Bhardwaj, Preeti Rawat, Preeti Sharma

    Background: Old age or elderly is the final stage of the normal life span. The elderly population is facing many health problems such as physical, mental, psychological and social etc. Factors like loneliness, low self-esteem, social isolation, quality of life and several others negatively affect elderly population and increase the risk of various health problems in elderly people. Methods: A cross sectional study was conducted, in which 200 elderly from Sirmour participated and the subjects were selected using total enumeration sampling technique. For the data collection the Semi-structured interview schedule, WHO brief-26 QoL assessment scale and Rosenberg self-esteem scale (10-items) were used and data was analyzed using descriptive and inferential statistics in SPSS version-23. Results: Present study shows that religion, education, occupation, monthly income have a very strong significant association at 0.05 level of significance with WHO bref-26 scale. Rosenberg self-esteem scale shows 165 (81.7%) of elderly have high self-esteem whereas 35 (17.3%) of them have low self-esteem. And no significant association was found between the self-esteem and demographic variable. Conclusions: Indicates that levels of QoL between elderly are moderate and many demographic, social and health factors are correlated with QoL. Also, no significant association was found between Rosenberg self-esteem scale with demographic variable.